Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Breed's Hill Capital was a wealth management firm specializing in investment management, estate and gift planning, tax planning, insurance, and asset protection for ultra-high-net-worth families. Prior to its acquisition by Corient on September 4, 2025, it managed approximately $3.5 billion in assets. The firm also had investments in real estate for life science redevelopment and held stakes in healthcare-related companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Breed’s Hill Capital.